Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Related articles

Indications for red blood cell transfusion in infants and children

INTRODUCTION

Transfusion of red blood cells (RBCs) can be life-saving in patients with severe blood loss or patients with severe chronic anemia. On the other hand, RBC transfusion has significant risks, including volume overload, transmission of infectious agents, transfusion reactions, and various immunologic consequences including graft-versus-host disease.

The indications for RBC transfusion in infants and children will be reviewed. The selection of the proper blood components, methods of administration, the complications of RBC transfusion and issues concerning blood donation and laboratory testing of donated blood are discussed separately. (See "Red cell transfusion in infants and children: Selection of blood products" and "Administration and complications of red cell transfusion in infants and children" and "Blood donor screening: Medical history" and "Blood donor screening: Laboratory testing" and "Red blood cell compatibility testing (crossmatching)".)

PREVALENCE OF PEDIATRIC RED CELL TRANSFUSION

The transfusion rate for any blood component in hospitalized children remains uncertain. In children hospitalized at academic children's hospitals, the rate of transfusion of either RBCs or platelets is approximately 5 percent.

This was best illustrated at a multicenter study from the Pediatric Health Information System of hospitalized patients who were 18 years or younger between 2001 and 2003 cared for at 35 academic children's hospitals [1]. Of the approximately one million hospitalized children in this database, RBC transfusions were performed in 4 percent and platelet transfusions in 1 percent of the patients. The distribution of transfusion based upon age was as follows:

Neonates (patients less than 30 days of age) - 17.5 percent

              

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jul 2014. | This topic last updated: Jun 11, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Slonim AD, Joseph JG, Turenne WM, et al. Blood transfusions in children: a multi-institutional analysis of practices and complications. Transfusion 2008; 48:73.
  2. Roseff SD, Luban NL, Manno CS. Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 2002; 42:1398.
  3. Gibson BE, Todd A, Roberts I, et al. Transfusion guidelines for neonates and older children. Br J Haematol 2004; 124:433.
  4. Spence RK, Swisher SN. Red cell transfusion-the transfusion trigger. In: Clinical practice of transfusion medicine, 3rd, Petz LD, Swisher SN, Kleinman S, et al (Eds), Churchill Livingstone, New York 1996. p.177.
  5. CASE RB, BERGLUND E, SARNOFF SJ. Ventricular function. VII. Changes in coronary resistance and ventricular function resulting from acutely induced anemia and the effect thereon of coronary stenosis. Am J Med 1955; 18:397.
  6. Lacroix J, Hébert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007; 356:1609.
  7. Rouette J, Trottier H, Ducruet T, et al. Red blood cell transfusion threshold in postsurgical pediatric intensive care patients: a randomized clinical trial. Ann Surg 2010; 251:421.
  8. Homi J, Reynolds J, Skinner A, et al. General anaesthesia in sickle-cell disease. Br Med J 1979; 1:1599.
  9. Sloan SR, Benjamin RF, Friedman DF, et al. Transfusion medicine. In: Nathan and Oski's Hematology of Infancy and Childhood, 6th, Nathan DG, Orkin SH, Ginsberg D, Look AT (Eds), WB Saunders, Philadelphia 2003. p.1709.
  10. Agarwal AK, Hastings CA, and Feusner J. Hematologic supportive care for children with cancer. In: Principles and Practice of Pediatric Oncology, 6, Pizzo PA, Poplack DG (Eds), Lippincott Williams and Wilkins, Philadelphia 2011. p.1152.
  11. Carson JL, Duff A, Berlin JA, et al. Perioperative blood transfusion and postoperative mortality. JAMA 1998; 279:199.
  12. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 2002; 42:812.
  13. Haberkern CM, Neumayr LD, Orringer EP, et al. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood 1997; 89:1533.
  14. Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med 1995; 333:206.
  15. Riley AA, Arakawa Y, Worley S, et al. Circulating blood volumes: a review of measurement techniques and a meta-analysis in children. ASAIO J 2010; 56:260.
  16. Singer ST, Styles L, Bojanowski J, et al. Changing outcome of homozygous alpha-thalassemia: cautious optimism. J Pediatr Hematol Oncol 2000; 22:539.
  17. Williams GD, Bratton SL, Ramamoorthy C. Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery. Anesth Analg 1999; 89:57.
  18. Kwiatkowski JL, Manno CS. Blood transfusion support in pediatric cardiovascular surgery. Transfus Sci 1999; 21:63.
  19. Florentino-Pineda I, Blakemore LC, Thompson GH, et al. The Effect of epsilon-aminocaproic acid on perioperative blood loss in patients with idiopathic scoliosis undergoing posterior spinal fusion: a preliminary prospective study. Spine (Phila Pa 1976) 2001; 26:1147.
  20. Neilipovitz DT, Murto K, Hall L, et al. A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg 2001; 93:82.
  21. Erstad BL. Systemic hemostatic medications for reducing surgical blood loss. Ann Pharmacother 2001; 35:925.
  22. Davies MJ, Allen A, Kort H, et al. Prospective, randomized, double-blind study of high-dose aprotinin in pediatric cardiac operations. Ann Thorac Surg 1997; 63:497.
  23. Carrel TP, Schwanda M, Vogt PR, Turina MI. Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only. Ann Thorac Surg 1998; 66:153.
  24. Miller BE, Tosone SR, Tam VK, et al. Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. Ann Thorac Surg 1998; 66:535.
  25. Biswas AK, Lewis L, Sommerauer JF. Aprotinin in the management of life-threatening bleeding during extracorporeal life support. Perfusion 2000; 15:211.
  26. Oliver WC Jr, Santrach PJ, Danielson GK, et al. Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Ann Thorac Surg 2000; 70:1923.
  27. Seear MD, Wadsworth LD, Rogers PC, et al. The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. J Thorac Cardiovasc Surg 1989; 98:217.
  28. Reynolds LM, Nicolson SC, Jobes DR, et al. Desmopressin does not decrease bleeding after cardiac operation in young children. J Thorac Cardiovasc Surg 1993; 106:954.
  29. Stylianos S. Liver injury and damage control. Semin Pediatr Surg 2001; 10:23.
  30. Manno CS, Hedberg KW, Kim HC, et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood 1991; 77:930.
  31. Arnold DM, Fergusson DA, Chan AK, et al. Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. Anesth Analg 2006; 102:731.
  32. Copley LA, Richards BS, Safavi FZ, Newton PO. Hemodilution as a method to reduce transfusion requirements in adolescent spine fusion surgery. Spine (Phila Pa 1976) 1999; 24:219.
  33. Anand N, Idio FG Jr, Remer S, Hoppenfeld S. The effects of perioperative blood salvage and autologous blood donation on transfusion requirements in scoliosis surgery. J Spinal Disord 1998; 11:532.
  34. Franchini M, Gandini G, Regis D, et al. Recombinant human erythropoietin facilitates autologous blood collections in children undergoing corrective spinal surgery. Transfusion 2004; 44:1122.
  35. Sachs B, Delacy D, Green J, et al. Recombinant activated factor VII in spinal surgery: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial. Spine (Phila Pa 1976) 2007; 32:2285.
  36. Faberowski LW, Black S, Mickle JP. Blood loss and transfusion practice in the perioperative management of craniosynostosis repair. J Neurosurg Anesthesiol 1999; 11:167.
  37. Fearon JA, Weinthal J. The use of recombinant erythropoietin in the reduction of blood transfusion rates in craniosynostosis repair in infants and children. Plast Reconstr Surg 2002; 109:2190.
  38. Dahmani S, Orliaguet GA, Meyer PG, et al. Perioperative blood salvage during surgical correction of craniosynostosis in infants. Br J Anaesth 2000; 85:550.
  39. Hans P, Collin V, Bonhomme V, et al. Evaluation of acute normovolemic hemodilution for surgical repair of craniosynostosis. J Neurosurg Anesthesiol 2000; 12:33.
  40. Lindemann R, Haines AL. Evaluation and treatment of polycythemia in the neonate. In: Hematologic problems of the neonate, Christensen RD (Ed), WB Saunders, Philadelphia 2000. p.171.
  41. Ohls RK. Evaluation and treatment of anemia in the neonate. In: Hematologic problems of the neonate, Christensen RD (Ed), WB Saunders, Philadelphia 2000. p.137.
  42. Meliones JN, Hansell DR. Extracorporeal membrane oxygenation: the role of blood components. In: Supporting the pediatric transfusion recipient, Chambers LA, Issitt LA (Eds), American Association of Blood Banks, Bethesda 1994. p.87.
  43. Remacha AF, Badell I, Pujol-Moix N, et al. Hydrops fetalis-associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation. Blood 2002; 100:356.